Pages that link to "Q34312144"
Jump to navigation
Jump to search
The following pages link to CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function (Q34312144):
Displaying 14 items.
- A Quantitative and Qualitative Exploration of Photoaversion in Achromatopsia. (Q33905240) (← links)
- Personalized therapeutic strategies for patients with retinitis pigmentosa (Q35225949) (← links)
- New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning review (Q36048823) (← links)
- Intravitreal Ciliary Neurotrophic Factor Transiently Improves Cone-Mediated Function in a CNGB3-/- Mouse Model of Achromatopsia (Q36232212) (← links)
- Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF (Q37481542) (← links)
- The cone dysfunction syndromes (Q41225313) (← links)
- Correlation of Macular Focal Electroretinogram with Ellipsoid Zone Extension in Stargardt Disease. (Q41622265) (← links)
- Ciliary neurotrophic factor (CNTF) delivery to retina: an overview of current research advancements (Q47601916) (← links)
- Gene Therapy for Color Blindness. (Q52743745) (← links)
- Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber's Hereditary Optic Neuropathy. (Q55039934) (← links)
- Longitudinal Assessment of Retinal Structure in Achromatopsia Patients With Long-Term Follow-up (Q59797544) (← links)
- Therapeutic avenues for hereditary forms of retinal blindness (Q62127811) (← links)
- CNGB3-Achromatopsia Clinical Trial With CNTF: Diminished Rod Pathway Responses With No Evidence of Improvement in Cone Function (Q86863683) (← links)
- Impacts of ciliary neurotrophic factor on the retinal transcriptome in a mouse model of photoreceptor degeneration (Q92093794) (← links)